Research

This Week’s FOMC and BOJ Meetings Are the Biggest Variables… “Interest Rates and Oil Prices Have Become a Daily Concern”

SKSecurities Report Concerns Over Interest Rates and Oil Prices Resurface U.S. CPI Slightly Exceeds Expectations

kyoungeun kim
2026-09-14 07:46:27
[Edaily Reporter kyoungeun kim ] Analysts predict that the domestic stock market will fluctuate this week, with the Federal Open Market Committee (FOMC) and the Bank of Japan (BOJ) monetary policy meetings serving as the key variables. Amid high expectations for a U.S. interest rate hike, analysts say the Federal Reserve’s stance on further rate increases will be a decisive factor.
KOSPI and Exchange Rate Open Lower_(Seoul=Yonhap News) Reporter Lee Jae-hee = Employees are working in the trading room at Hana Bank’s headquarters in Jung-gu, Seoul, on the 11th. On this day, the KOSPI opened at 6,802.50, down 231.42 points (3.29%) from the previous close, and the won/dollar exchange rate stood at 1,347.30 won as of 9:00 a.m. September 11, 2026 scape@yna.co.kr

Cho Jun-ki, an analyst at SKSecurities, made this forecast in a report on the 14th, noting that the likelihood of a U.S. Federal Reserve interest rate hike has increased.
The U.S. August Consumer Price Index (CPI), released after the domestic stock market closed last weekend, showed a month-over-month increase of 0.3% for the core CPI, slightly exceeding the consensus estimate (0.2%). However, the figure generally remained within the range of market expectations.
Researcher Jo explained, “The narrative surrounding a benchmark interest rate hike—fueled by recent strong employment data and rising oil prices—has not shifted back toward a rate freeze,” adding, “Since Fed Chair Wash has significantly reduced preemptive communication with the market compared to the Powell administration, economic indicators and price trends now directly and immediately influence market expectations.”
The biggest events this week are the FOMC and the Bank of Japan’s (BOJ) Monetary Policy Meeting. The U.S. benchmark interest rate appears to be leaning toward a 25 basis point (0.25 percentage point) hike. As the market digested this week’s sharp rise in oil prices and the August U.S. Producer Price Index (PPI) and Consumer Price Index (CPI) data, the probability of a September rate hike rose from around 60% to nearly 90% according to the Chicago Mercantile Exchange (CME) FedWatch, and the projected path now reflects two hikes this year and four by next year.
Researcher Cho noted, “Even if the benchmark interest rate is raised, if the Fed confirms a conservative stance on further hikes, it will be perceived as a ‘dovish hike,’ and I place greater weight on the possibility of a favorable market reaction.” However, he added, “If the Fed were to unexpectedly keep rates unchanged, it could actually have a negative impact.”
The direction of oil prices is also cited as a key variable. West Texas Intermediate (WTI) crude, which rose to a high of $107 last week, fell to around $96 per barrel for indefinite-term futures over the weekend. The peak for WTI during the period when geopolitical risks were at their highest this year was around $118.
Analyst Cho assessed, “In the short term, the main market variables are long-term interest rates and oil prices,” adding, “This is an environment where a significant style rotation could occur depending on oil prices and the FOMC’s tone (whether the path for further rate hikes is limited will determine the direction of long-term interest rates).” He continued, “Assuming oil prices do not rise further, a dovish rate hike is likely to favor high-beta stocks such as growth and tech, while a hawkish rate hike is likely to shift the focus toward value stocks and low-volatility stocks.”

Economy

Corporation

IT·Science

Economy

Lisa Su Meets with Jeon Young-hyun for 3 Hours… “Broad Partnership” for Foundry Collaboration

Lisa Su, Chairwoman and CEO of AMD, concluded a meeting lasting over three hours with Jeon Young-hyun, President and CEO of SamsungElectronics and Vice Chairman in charge of the Device Solutions (DS) …
2026-10-07 20:35:47

Corporation

South Korea Enters the 160 Trillion Global Obesity Drug Market… HanmiGlobal Co., Ltd’s “Epe” Becomes First Domestically Developed Drug to Receive Approval

Epfeglenatide, developed by HanmiPharm, has received approval from the Ministry of Food and Drug Safety as the first domestically developed GLP-1-based obesity treatment. With this approval, Korea has…
2026-10-07 19:34:02

IT·Science

A Twist in the Story of the New Drug Rejected by Sanofi… Hanmi’s “Epe” Becomes the First Domestically Developed GLP-1 Weight-Loss Drug to Receive Approval

A new domestically developed drug has emerged to compete in the obesity treatment market, which is currently dominated by global pharmaceutical companies. With HanmiPharm’s efeglenatide receiving mark…
2026-10-07 18:22:02